Literature DB >> 14633595

Reconstructed beta-catenin/TCF4 signaling in yeast applicable to functional evaluation of APC mutations.

Hidehisa Yamada1, Keiji Furuuchi, Tetsuya Aoyama, Akihiko Kataoka, Jun-ichi Hamada, Mitsuhiro Tada, Shunichi Okushiba, Satoshi Kondo, Tetsuya Moriuchi, Hiroyuki Katoh.   

Abstract

In human genetics and molecular oncology, mutation research is necessary not only to identify mutations in nucleic acid sequences, but also to analyze the loss of function caused by mutant proteins. We reconstructed a protein-protein network system of human beta-catenin and TCF4, in Saccharomyces cerevisiae. beta-Catenin and TCF4 proteins form a complex and transactivate reporter genes. Co-expressed wild-type APC with beta-catenin and TCF4 inhibit the transcriptional activity of the beta-catenin/TCF4 complex in yeast, as well as in mammals. This unique method in which the beta-catenin/TCF4 signaling pathway is reconstructed in vivo may prove useful for the functional evaluation of APC mutants, including a type of APC truncated and missense mutants influenced to the ability of binding to beta-catenin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14633595      PMCID: PMC1892379          DOI: 10.1016/s0002-9440(10)63578-x

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  35 in total

1.  APC-mediated downregulation of beta-catenin activity involves nuclear sequestration and nuclear export.

Authors:  K L Neufeld; F Zhang; B R Cullen; R L White
Journal:  EMBO Rep       Date:  2000-12       Impact factor: 8.807

2.  Use of G-protein fusions to monitor integral membrane protein-protein interactions in yeast.

Authors:  K N Ehrhard; J J Jacoby; X Y Fu; R Jahn; H G Dohlman
Journal:  Nat Biotechnol       Date:  2000-10       Impact factor: 54.908

3.  The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression.

Authors:  I M Shih; J Yu; T C He; B Vogelstein; K W Kinzler
Journal:  Cancer Res       Date:  2000-03-15       Impact factor: 12.701

Review 4.  The ABC of APC.

Authors:  N S Fearnhead; M P Britton; W F Bodmer
Journal:  Hum Mol Genet       Date:  2001-04       Impact factor: 6.150

5.  Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317Q.

Authors:  H Lamlum; N Al Tassan; E Jaeger; I Frayling; O Sieber; F B Reza; M Eckert; A Rowan; E Barclay; W Atkin; C Williams; J Gilbert; J Cheadle; J Bell; R Houlston; W Bodmer; J Sampson; I Tomlinson
Journal:  Hum Mol Genet       Date:  2000-09-22       Impact factor: 6.150

6.  Development of a yeast stop codon assay readily and generally applicable to human genes.

Authors:  A Kataoka; M Tada; M Yano; K Furuuchi; S Cornain; J Hamada; G Suzuki; H Yamada; S Todo; T Moriuchi
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

7.  Adenomatous polyposis coli protein contains two nuclear export signals and shuttles between the nucleus and cytoplasm.

Authors:  K L Neufeld; D A Nix; H Bogerd; Y Kang; M C Beckerle; B R Cullen; R L White
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

8.  Dominant-negative mutations of the tumor suppressor p53 relating to early onset of glioblastoma multiforme.

Authors:  M Marutani; H Tonoki; M Tada; M Takahashi; H Kashiwazaki; Y Hida; J Hamada; M Asaka; T Moriuchi
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

9.  Multiple methods of visualizing the yeast vacuole permit evaluation of its morphology and inheritance during the cell cycle.

Authors:  L S Weisman; R Bacallao; W Wickner
Journal:  J Cell Biol       Date:  1987-10       Impact factor: 10.539

10.  A yeast model system for functional analysis of beta-catenin signaling.

Authors:  Margaret S Lee; Karen A D'Amour; Jackie Papkoff
Journal:  J Cell Biol       Date:  2002-09-16       Impact factor: 10.539

View more
  1 in total

1.  ABCB1 and ABCG2 drug transporters are differentially expressed in non-small cell lung cancers (NSCLC) and expression is modified by cisplatin treatment via altered Wnt signaling.

Authors:  M Vesel; J Rapp; D Feller; E Kiss; L Jaromi; M Meggyes; G Miskei; B Duga; G Smuk; T Laszlo; I Karner; J E Pongracz
Journal:  Respir Res       Date:  2017-03-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.